<DOC>
	<DOCNO>NCT00299780</DOCNO>
	<brief_summary>The purpose study determine safety parathyroid hormone combination G-CSF use stem cell mobilization regimen patient fail mobilize sufficient progenitor stem cell one two attempt .</brief_summary>
	<brief_title>Safety Study Parathyroid Hormone Patients Needing Additional Stem Cell Mobilization .</brief_title>
	<detailed_description>Patients start treatment within 21 day determination inadequate mobilization . PTH treatment give 4 cohort : 40 mcg , 60 mcg , 80 mcg , 10 mcg . PTH give day 1 continue stem cell collection complete maximum 20 day . G-CSF 10 mcg/kg give day 10-14 continue stem cell collection complete . Patients inadequate CD34+ cell Day 14 meet study criterion continue PTH/G-CSF .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Disease status : NHL HD refractory chemotherapy , relapse , high risk first remission ; multiple myeloma ; AML second subsequent remission first remission adverse cytogenetics antecedent hematologic disorder . Failed one two mobilization attempt . ECOG performance status 0 , 1 , 2 . Cardiac disease : symptomatic congestive heart failure , angina pectoris uncontrolled hypertension Pulmonary disease : severe chronic obstructive lung disease , symptomatic restrictive lung disease . Renal disease : serum creatinine &gt; 2 mg/dl Hepatic disease : SGOT SGPT &gt; 3x normal ; serum bilirubin &gt; 2.0 mg/dl due Gilbert 's syndrome hemolysis Calcium &gt; 10.5 Phosphate &lt; 1.6 Uncontrolled infection Pregnancy breast feeding mother</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Mobilization</keyword>
	<keyword>Stem Cell</keyword>
	<keyword>Parathyroid Hormone</keyword>
</DOC>